Stockreport

Nuvation Bio says preliminary Q4 and FY25 IBTROZI net product revenue was $15.7M and $24.7M [Seeking Alpha]

Nuvation Bio Inc. Class A  (NUVB) 
PDF Received $25 million milestone payment from Nippon Kayaku as a result of establishment of the reimbursement price in Japan in Q4. Preliminary unaudited cash, cash equ [Read more]